ArticleCurrent opinion in biomedical engineering2026
Gero-Immunology: The critical role of aging when defining immune phenotypes.
Article in Current opinion in biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The immune system is complex, dynamic, and essential for organismal health. As organisms age, immune cells undergo numerous changes that often limit their ability to fight infections, eradicate diseases, and tolerate foreign entities. Although many studies have advanced our understanding of key immune functions, many overlook the effects of age, which can potentially limit the generalizability of their findings. In this review, we argue that age should be critically considered when designing in vitro models of the immune system. We begin by outlining some practical and conceptual challenges that limit the inclusion of age in immune models. We then propose practical strategies that researchers can use to account for age effects and summarize recent findings that demonstrate how aging alters cellular immune functions to drive immune dysfunction. Lastly, pose open questions that could benefit from bioengineering solutions and look ahead to how considering age can improve model fidelity, increase translational value, and accelerate discoveries that are both relevant and generalizable across the lifespan.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.